Therapeutics/toxicology Flashcards

1
Q

Malignant hyperthermia associated with

A

Anaesthetic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Neuroleptic malignant syndrome associated with which drugs

A

Antipsychotics
Dopaminergics (Levodopa) if stopped suddenly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Serotonin syndrome associated with which drugs

A

SSRIs (includes Tramadol)
MAO inhibitors
Amphetamine/MDMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Initial management of theophylline poisoning

A

Multiple dose activated charcoal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2nd line management of theophylline poisoning

A

Haemodialysis/charcoal haemoperfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Features of theophylline poisoning

A

Hypokalaemia, acidosis
Arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which medication should be stopped on starting DAPT

A

Omeprazole - inhibits clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Nitrofurantoin - risks in long-term use

A

Folate deficiency
Pulmonary fibrosis
SLE-like syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Uses of doxazosin

A

Resistant HTN
BPH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Uses of duloxetine

A

Depression/anxiety
Neuropathic pain
STRESS incontinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

1st line management of urge incontinence

A

Bladder training 6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

2nd line management of urge incontinence

A

Anti-muscarinics (oxybutynin > tolteradine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

2nd line management of urge incontinence if anti-muscarinics not appropriate

A

Mirabegron (beta-3 agonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

1st line management of stress incontinence

A

Pelvic floor training 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

3rd line management of urge incontinence

A

Botox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

2nd line management of stress incontinence

A

Surgery: retropubic mid-urethral tape

17
Q

2nd line management of stress incontinence - if surgery not appropriate

A

Duloxetine

18
Q

Adverse effects of trimethoprim

A

Myelosuppression
Transient rise in creatinine

19
Q

Adverse effects of Efavirenz (NNRTI)

A

Nightmares
Confusion

20
Q

Adverse effect of Abacavir (NRTI)

A

Hypersensitivity reaction associated with HLA-B*5701

21
Q

Side effects of Tenofovir (NRTI)

A

Renal impairment
GI upset
Osteoporosis

22
Q

General adverse effects of NRTIs

A

Peripheral neuropathy
Lactic acidosis

23
Q

Trastuzumab (anti-HER2/neu) side effects

A

Cardiotoxicity, especially when anthracyclines (Doxorubicin) have been given

24
Q

Morbiliform rash + raised eosinophils after starting anti-epileptic/antibiotic/HAART

A

DRESS (drug reaction with eosinophilia and systemic symptoms)

25
Management of Amiodarone-induced thyrotoxicosis type 2 (amiodarone-related destructive thyroiditis)
Corticosteroids
26
Management of Amiodarone-induced thyrotoxicosis type 1 (excess iodine-induced thyroid hormone synthesis)
Carbimazole +/- potassium perchlorate
27
Aspirin overdose - salicylate serum level requiring haemodialysis
> 700 mg/L
28
Treatment of methanol poisoning
Fomepizole Folinic acid to prevent opthalmological complications
29
Features of Cinchonism (quinine toxicity)
Tinnitus Blurred vision Nausea Arrhythma
30
Poisoning showing high anion gap (>16) and high osmolar gap (10), think..
Ethylene glycol toxicity
31
Side effects of Pyrazinamide
Arthralgia + myalgia Gout Hepatitis
32
Indications for desferrioxamine in iron overdose
Serum iron >90 umol/L Serum iron 60-90 and symptomatic, or iron visible on AXR despite irrigation Shock, coma, metabolic acidosis
33
Acute management of hereditary angioedema
IV C1 esterase inhibitor FFP if not available